Endocrinology, Vol 114, 753-760, Copyright © 1984 by Endocrine Society

ARTICLES

Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes

DE Peavy, JW Edmondson and WC Duckworth

Several compounds known to alter receptor-mediated endocytosis were tested for their effect on insulin action in isolated rat hepatocytes. Dansylcadaverine blocked the inhibitory effect of insulin on hepatic protein degradation, but was without effect on the inhibition produced by high concentrations of amino acids. Dansylcadaverine also was without effect on the stimulatory action of insulin on glucose incorporation into glycogen, but totally blocked the insulin stimulation of alanine uptake. No inhibition of basal or (Bu)2cAMP- stimulated alanine uptake was observed with dansylcadaverine. These results indicate that dansylcadaverine has selective effects on some but not all of insulin's actions. Methylamine also blocked insulin stimulation of alanine transport, although at higher doses, methylamine decreased basal and (Bu)2cAMP-stimulated uptake due to cellular toxicity. Chloroquine, an inhibitor of intracellular insulin processing, had no effect on insulin-stimulated alanine transport. To examine the site of action of dansylcadaverine on insulin processing, the binding (cell-associated radioactivity) and degradation of [125I]iodoinsulin by hepatocytes were examined in the presence and absence of dansylcadaverine. Dansylcadaverine delayed the time required to achieve maximal insulin binding and produced a dose-dependent decrease in cell-mediated insulin degradation. Acid dissociation and proteolytic digestion methods were used to differentiate between [125I]iodoinsulin bound to the cell surface vs. that which had been internalized. Dansylcadaverine did not block internalization as measured by either of these criteria, but did block the increase in cell-associated radioactivity produced by chloroquine, suggesting that dansylcadaverine blocks insulin processing after internalization but before the chloroquine-sensitive step. These data show that some of the hepatic actions of insulin, namely inhibition of protein degradation and stimulation of alanine transport, are blocked by certain inhibitors of cellular hormone processing, suggesting that these actions of insulin may require postreceptor events involving insulin metabolism.

This article has been cited by other articles:

				T. P. Ciaraldi, S. A. Phillips, L. Carter, V. Aroda, S. Mudaliar, and R. R. Henry Effects of the Rapid-Acting Insulin Analog Glulisine on Cultured Human Skeletal Muscle Cells: Comparisons with Insulin and Insulin-Like Growth Factor I J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5551 - 5558. [Abstract] [Full Text] [PDF]

				R. G. Bennett, F. G. Hamel, and W. C. Duckworth An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures Diabetes, September 1, 2003; 52(9): 2315 - 2320. [Abstract] [Full Text] [PDF]

				F. G. Hamel, J. L. Upward, and R. G. Bennett In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters Endocrinology, June 1, 2003; 144(6): 2404 - 2408. [Abstract] [Full Text] [PDF]

				Z. Zhang and J. Radziuk Inverse relationship between peripheral insulin removal and action: studies with metformin Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1240 - E1248. [Abstract] [Full Text] [PDF]

				Z. Vajo, J. Fawcett, and W. C. Duckworth Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs Endocr. Rev., October 1, 2001; 22(5): 706 - 717. [Abstract] [Full Text] [PDF]

				F. G. Hamel, R. G. Bennett, J. L. Upward, and W. C. Duckworth Insulin Inhibits Peroxisomal Fatty Acid Oxidation in Isolated Rat Hepatocytes Endocrinology, June 1, 2001; 142(6): 2702 - 2706. [Abstract] [Full Text] [PDF]

				M. L. Hribal, R. D'Alfonso, B. Giovannone, D. Lauro, Y. Y. Liu, P. Borboni, M. Federici, R. Lauro, and G. Sesti The Sulfonylurea Glimepiride Regulates Intracellular Routing of the Insulin-Receptor Complexes through Their Interaction with Specific Protein Kinase C Isoforms Mol. Pharmacol., February 1, 2001; 59(2): 322 - 330. [Abstract] [Full Text]

				S. Schutze, T. Machleidt, D. Adam, R. Schwandner, K. Wiegmann, M.-L. Kruse, M. Heinrich, M. Wickel, and M. Kronke Inhibition of Receptor Internalization by Monodansylcadaverine Selectively Blocks p55 Tumor Necrosis Factor Receptor Death Domain Signaling J. Biol. Chem., April 9, 1999; 274(15): 10203 - 10212. [Abstract] [Full Text] [PDF]

				W. C. Duckworth, R. G. Bennett, and F. G. Hamel Insulin Degradation: Progress and Potential Endocr. Rev., October 1, 1998; 19(5): 608 - 624. [Abstract] [Full Text]

				F. G. Hamel, R. G. Bennett, and W. C. Duckworth Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme Endocrinology, October 1, 1998; 139(10): 4061 - 4066. [Abstract] [Full Text] [PDF]

				J. C. Chow, G. Condorelli, and R. J. Smith Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 Pathway J. Biol. Chem., February 20, 1998; 273(8): 4672 - 4680. [Abstract] [Full Text] [PDF]

				R. Roth Structure of the receptor for insulin-like growth factor II: the puzzle amplified Science, March 11, 1988; 239(4845): 1269 - 1271. [Abstract] [PDF]

				J. Fawcett, F. G. Hamel, R. G. Bennett, Z. Vajo, and W. C. Duckworth Insulin and Analogue Effects on Protein Degradation in Different Cell Types. DISSOCIATION BETWEEN BINDING AND ACTIVITY J. Biol. Chem., April 6, 2001; 276(15): 11552 - 11558. [Abstract] [Full Text] [PDF]